
Gema Diagnostics: A Michigan-based molecular diagnostics firm specializing in assisted reproductive technology.
Gema Diagnostics, founded in East Lansing, Michigan, is a molecular diagnostics company specializing in assisted reproductive technology. The company's core mission is to enhance the success rates of in vitro fertilization (IVF) through advanced diagnostic tools. Gema Diagnostics offers innovative molecular diagnostic products designed to improve embryo selection and overall IVF outcomes, focusing on providing cutting-edge solutions for fertility clinics and patients.
Notable figures affiliated with Gema Diagnostics include experts in molecular biology and reproductive medicine. The company has garnered attention from investors interested in advancing reproductive health technologies. Key achievements include the development of proprietary diagnostic methods that have shown promise in clinical settings, contributing to higher IVF success rates. Gema Diagnostics' impact lies in its potential to transform the landscape of assisted reproductive technology, offering hope and improved outcomes for individuals and couples seeking fertility treatments.

Empowered Diagnostics

GeneDx Holdings
genedx.com

Gamma Diagnostics

Iverson Genetic Diagnostics

TAI Diagnostics

Iv Diagnostics

Gregor Diagnostics

Gemelli Biotech
gemellibiotech.com

Juno Diagnostics

Ovagene Oncology

Genendeavor
genendeavor.com

Myriad Genetics
myriad.com

Test Diagnostics

Prompt Diagnostics
prompt-dx.com

Amplified Sciences
Companies similar to Gema Diagnostics include Empowered Diagnostics, GeneDx Holdings, Gamma Diagnostics and Iverson Genetic Diagnostics.
Gema Diagnostics was founded in 2005.
Gema Diagnostics' headquarters is located in Ann Arbor, MI, US.
Gema Diagnostics' most recent funding round was for $625k (USD) in April 2013.
As of Apr 8, 2013, Gema Diagnostics has raised a total of $3.3M (USD).
Gema Diagnostics has 5 employees as of Feb 5, 2024.